ENTITY
Akeso Biopharma Inc

Akeso Biopharma Inc (9926 HK)

211
Analysis
Health CareChina
Akeso Inc. operates operatesa s a biotech company. The compnay develops treatments and therapies for various types of diseases. Akeso serves cutomers worldwide
more
22 Jul 2020 05:39

HSCI and Stock Connect - Biotech Stocks Now Eligible; Inclusion & Exclusion Possibilities

Hang Seng Indexes Company (HSIL) reviews the constituents of the Hang Seng Composite Index (HSCI) on a half yearly basis in March and September...

Logo
772 Views
Share
15 Jul 2020 12:47

HK IPO Analytics 1H2020: Highlight of Brokers' and Sectors' Performance, and Insti Book Color

As we regularly analyse deal performance, it is time to look at how the HK IPO markets performed during the first half of 2020. In this note, we...

Logo
444 Views
Share
09 Jul 2020 13:29

Ocumension Therapeutics IPO: Trading Debut

Ocumension Therapeutics (1477 HK) is a China-based ophthalmic pharmaceutical company dedicated to identifying, developing and commercializing...

Logo
405 Views
Share
bullishHKEX
06 Jun 2020 04:07

HKEx (388.HK): Trading Volume in May Points to Upside and New License Agreement with MSCI

HKEX (388 HK) just released its May market statistics. The May month ADT (Average Daily Turnover) has registered 14% month-to-month rebound to HKD...

Logo
Roger Xie
415 Views
Share
12 May 2020 14:57

Kintor Pharma IPO: Valuation Insights

Kintor Pharmaceutical (9939 HK) is a clinical-stage drug developer with a focus on potential first-in-class and best-in-class drugs for cancers and...

Logo
334 Views
Share
x